US-based Thermo Fisher Scientific has announced the launch of the Thermo Scientific Multiskan Ease Absorbance Microplate...
Shanghai-based DualityBio has entered a global collaboration and licensing agreement with Genentech to develop next-gene...
What are Caidya’s major highlights for 2026 that will strengthen its presence in the global CRO market? And what a...
US-based Celularity Inc., a longevity-focused regenerative and cellular medicine company, and Singaporean startup M...
Artificial intelligence is increasingly being applied across early-stage drug discovery, but translating computational p...
Genentech, a member of the Roche Group, has announced plans to invest approximately $750 million in a new device fill-fi...
Brown University Health and Arcamyra Therapeutics are preparing to launch a Phase I clinical trial of ACM-CpG in patient...
Andelyn Biosciences has partnered with Queen’s University to develop and manufacture AAV9-GM2, an investigational ...
Apodex has launched TRACES, a benchmark designed to evaluate how artificial intelligence systems perform on open-ended s...
In conversation with BioSpectrum Asia, Laurie Masiello and John Masiello, Co-Founders of Predictive Monitor, explore how...
Ascletis Pharma has initiated two Phase I studies in the United States evaluating investigational once-monthly injectabl...
Thermo Fisher Scientific Inc., the world leader in serving science, has announced the completion of Olink Explore HT pro...
Bristol Myers Squibb (BMS) has announced the selection of Houston, Texas, as the site for a new, state-of-the-art multi-...
Moderna, Inc. has announced that the US Food and Drug Administration (FDA) has approved mFLUSIVA® (mRNA-1010), a new...
Scientists at Northwestern University have found that tissue environments surrounding persistent viral reservoirs share ...
The US Food and Drug Administration has approved Moderna’s mFlusiva seasonal influenza vaccine for adults aged 50 ...
A Phase III clinical trial has found that adding high-dose vitamin D3 to chemotherapy and bevacizumab does not improve p...
Researchers at Stony Brook Cancer Center have developed an experimental RNA-based therapy that reduced non-small cell lu...
US-based Waters Corporation has announced the launch of the Xevo TQ Absolute XR IVD Mass Spectrometer, expanding it...
Devonian Health Group has received Health Canada authorisation to initiate a Phase II/III paediatric clinical trial of P...
Nektar Therapeutics has initiated the first two global registrational trials in its Phase 3 ZENITH AD programme for rezp...
Alebund Pharmaceuticals has randomised and dosed the first participant in its global Phase IIb multi-regional clinical t...
ING has examined the shifting global pharmaceutical landscape in a podcast discussion focused on China’s biotech b...
South Korea-based Seegene, Inc., a global leader in molecular diagnostics, has announced that its US subsidiary, Seegene...
BioLineRx and Hemispherian will present preclinical data on GLIX1 at the 2026 European Society for Medical Oncology Annu...
